Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a peptide that could lead to the early detection of Alzheimer’s disease (AD). The discovery, published in Nature Communications, may also provide a means of homing drugs to diseased areas of the brain to treat AD, Parkinson’s disease, as well as glioblastoma, brain injuries and stroke.
from Dementia Big http://ift.tt/2hZbWly via alcoholic dementia
http://ift.tt/2yqZzF3
No comments:
Post a Comment